Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with (64)Cu Using NOTA and NODAGA

Imaging using affibody molecules enables discrimination between breast cancer metastases with high and low expression of HER2, making appropriate therapy selection possible. This study aimed to evaluate if the longer half-life of (64)Cu (T(1/2) = 12.7 h) would make (64)Cu a superior nuclide compared...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Contrast Media Mol Imaging
Huvudupphovsmän: Tolmachev, Vladimir, Yim, Cheng-Bin, Rajander, Johan, Perols, Anna, Karlström, Amelie Eriksson, Haaparanta-Solin, Merja, Grönroos, Tove J., Solin, Olof, Orlova, Anna
Materialtyp: Artigo
Språk:Inglês
Publicerad: Hindawi Publishing Corporation 2017
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5612711/
https://ncbi.nlm.nih.gov/pubmed/29097939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8565802
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk